**Question:** All of the following drugs may be used in the treatment of ulcerative colitis Except:

A. Mesalamine (5-ASA)
B. Prednisolone
C. Azathioprine
D. Infliximab

**Core Concept:** Ulcerative colitis is a type of inflammatory bowel disease (IBD) affecting the colon. Treatment options for ulcerative colitis generally aim to suppress inflammation, alleviate symptoms, and prevent complications.

**Why the Correct Answer is Right:**

Option D - Infliximab (Remicade): This is a monoclonal antibody targeting tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine involved in the pathogenesis of IBD. Infliximab is typically used as a biologic agent for moderate to severe ulcerative colitis, especially in patients not responding to conventional therapies.

Option A - Mesalamine (5-ASA): Mesalamine (5-aminosalicylic acid) is a local anti-inflammatory agent that reduces inflammation in the affected colon. It is often used as a first-line therapy for mild to moderate ulcerative colitis.

Option B - Prednisolone: Prednisolone is a corticosteroid with anti-inflammatory properties. It can be used as a short-term treatment for severe ulcerative colitis to suppress inflammation and alleviate symptoms. However, its long-term use is limited due to potential side effects.

Option C - Azathioprine: Azathioprine is an immunosuppressant used to reduce the immune system's activity in patients with IBD. It is often used as a maintenance therapy to prevent relapses in patients with mild to moderate ulcerative colitis.

**Why Each Wrong Option is Incorrect:**

Option C - Azathioprine: Although azathioprine can be effective in preventing relapses in patients with ulcerative colitis, it is generally not used as a first-line therapy due to its potential side effects and the availability of more specific treatments.

Option B - Prednisolone: While prednisolone can be effective in treating severe ulcerative colitis, its long-term use is limited due to significant side effects, including osteoporosis, diabetes, and infections.

Option A - Mesalamine (5-ASA): Mesalamine is less potent than azathioprine or prednisolone, making it unsuitable for severe ulcerative colitis cases.

Option D - Infliximab: While Infliximab is an effective biologic agent for severe ulcerative colitis, it is not suitable for mild to moderate cases due to its limited efficacy and potential side effects.

**Clinical Pearl:** In general, the choice of therapy for ulcerative colitis depends on disease severity and patient-specific factors. Mild to moderate cases may be managed with mesalamine, azathioprine, or corticosteroids, while severe cases may require corticosteroids, biologic agents like infliximab, or combination therapy.